Move Over Roivant, Nuvation: EQRx Reveals Biggest Biopharma SPAC Merger This Year

Deal Gives Developer Of Low-Cost Drugs $1.8bn In New Cash

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.